Top

Published in:

01-01-2014 | Key Review Article

Ocular Involvement in Primary Immunodeficiency Diseases

Authors: Sima Hosseinverdi, Hassan Hashemi, Asghar Aghamohammadi, Hans D. Ochs, Nima Rezaei

Published in: Journal of Clinical Immunology | Issue 1/2014

Abstract

Primary immunodeficiency diseases (PID) are a group of inherited disorders characterized by recurrent infections, and in many cases autoimmunity and malignancies. A number of PID patients suffer from a variety of ocular manifestations. Although these associated ocular features are not common, awareness combined with better understanding of the contributing mechanisms will allow prompt diagnosis and specific treatment, leading to reduction or prevention of serious visual morbidities.

Al-Herz W, Bousfiha A, Casanova JL, Chapel H, Conley ME, Cunningham-Rundles C, et al. Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol. 2011;2:54.PubMedCentralPubMed

Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev. 2000;13:662–85.PubMedCentralPubMed

Gennery AR, Cant AJ. Diagnosis of severe combined immunodeficiency. J Clin Pathol. 2001;54:191–5.PubMed

Gaspar HB, Gilmour KC, Jones AM. Severe combined immunodeficiency–molecular pathogenesis and diagnosis. Arch Dis Child. 2001;84:169–73.PubMed

Boone WB, O’Reilly RJ, Pahwa S, Grimes E, Smithwick EM, Good RA. Acquired CMV Chorioretinitis in Severe Combined lmmunodeficiency. Clin Immunol Immunopathol. 1978;9:129–33.PubMed

Perren BA, Raisanen J, Good WV, Crawford JB. Cytomegalovirus retinitis and optic neuritis in a child with severe combined immunodeficiency syndrome. Retina. 1996;16:117–21.PubMed

Baumal CR, Levin AV, Read SE. Cytomegalovirus Retinitis in Immunosuppressed Children. Am J Ophthalmol. 1999;127:550–8.PubMed

Borne MJ, Shields JA, Shields CL, De Porter P, Ehya H. Bilateral Viral Endophthalmitis as the Presenting Sign of Severe Combined Immunodeficiency. Arch Ophthalmol. 1994;112:1280–1.PubMed

Barrett L, Walmsley S. CMV retinopathy in the antiretroviral therapy era: prevention, diagnosis, and management. Curr Infect Dis Rep. 2012;14:435–44.PubMed

10.

Aghamohammadi A, Fiorini M, Moin M, Parvaneh N, Teimourian S, Yeganeh M, et al. Clinical, immunological and molecular characteristics of 37 Iranian patients with X-linked agammaglobulinemia. Int Arch Allergy Immunol. 2006;141:408–14.PubMed

11.

Moin M, Aghamohammadi A, Farhoudi A, Pourpak Z, Rezaei N, Movahedi M, et al. X-linked agammaglobulinemia: a survey of 33 Iranian patients. Immunol Invest. 2004;33:81–93.PubMed

12.

Rezaei N, Hedayat M, Aghamohammadi A, Nichols KE. Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies. J Allergy Clin Immunol. 2011;127:1329–41.e2.PubMed

13.

Moise A, Nedelcu FD, Toader MA, Sora SM, Tica A, Ferastraoaru DE, et al. Primary immunodeficiencies of the B lymphocyte. J Med Life. 2010;3:60–3.PubMedCentralPubMed

14.

Franklin RM, Winkelstein JA, Seto DS. 1977. Conjunctivitis and keratoconjunctivitis associated with primary immunodeficiency diseases. Am J Ophthalmol 84

15.

al Ghonaium A, Ziegler JB, Tridgell D. Bilateral chronic conjunctivitis and corneal scarring in a boy with X-linked hypogammaglobulinemia. J Paediatr Child Health. 1996;32:463–5.PubMed

16.

Hansel TT, O’Neill DP, Yee ML, Gibson JM, Thompson RA. Infective conjunctivitis and corneal scarring in three brothers with sex linked hypogammaglobulinaemia (Bruton’s disease). Br J Ophthalmol. 1990;74:118–20.PubMed

17.

Reisli I, Artac H, van der Burg M, Ozturk B. Iris atrophy in a patient with X-linked Agammaglobulinemia. Can J Ophthalmol. 2007;42:882–3.PubMed

18.

Aghamohammadi A, Parvaneh N, Rezaei N. Common variable immunodeficiency: a heterogeneous group needs further subclassification. Expert Rev Clin Immunol. 2009;5:629–31.PubMed

19.

Cunningham-Rundles C, Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol. 1999;92:34–8.PubMed

20.

Aghamohammadi A, Farhoudi A, Moin M, Rezaei N, Kouhi A, Pourpak Z, et al. Clinical and immunological features of 65 Iranian patients with common variable immunodeficiency. Clin Diagn Lab Immunol. 2005;12:825–32.PubMedCentralPubMed

21.

Oltra EZ, Morris C, Birnbaum AD, Tessler HH, Goldstein DA. Chronic Anterior Uveitis in Common Variable Immunodeficiency. Ocul Immunol Inflamm. 2011;19:448–9.PubMed

22.

Artac H, Bozkurt B, Talim B, Reisli I. Sarcoid like granulomas in common variable immunodeWciency. Rheumatol Int. 2009;30:109–12.PubMed

23.

Harsum S, Lear S, Wilson P. CVID causing a granulomatous uveitis and optic disc neovascularisation mimicking sarcoid. Eye (Lond). 2009;23:241–2.

24.

Pasquet F, Kodjikian L, Mura F, Riviere S. Uveitis and common variable immunodeficiency: data from the DEF-I study and literature review. Ocul Immunol Inflamm. 2012;20:163–70.

25.

Gray R, Vodden J, Gompels M. Uveitis in a patient with common variable immunodeficiency. Eye (Lond). 2003;17:99–101.

26.

Lever AM, Dolby JM, Webster AD. Chronic campylobacter colitis and uveitis in patient with hypogammaglobulinaemia. Br Med J (Clin Res Ed). 1984;18:531.

27.

Cohen VM, Lee JA, Egner W, Whyte MK, Rennie IG. Bilateral granulomatous uveitis in association with common variable immunodeficiency. Br J Ophthalmol. 2001;85:630–1.PubMed

28.

Arnold DF, Wiggins J, Cunningham-Rundles C, Misbah SA, Chapel HM. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin Immunol. 2008;128:18–22.PubMedCentralPubMed

29.

Brandt D, Gershwin ME. Common variable immune deficiency and autoimmunity. Autoimmun Rev. 2006;5:465–70.PubMed

30.

van Meurs JC, Lightman S, de Waard PW, Baarsma GS, van Suijlekom-Smit LW, van de Merwe JP, et al. Retinal vasculitis occurring with common variable immunodeficiency syndrome. Am J Ophthalmol. 2000;129:269–70.PubMed

31.

Mehta P, Chickadasarahally S, Ahluwalia H. Orbital inflammation: a rare association of common variable immunodeficiency. Orbit. 2011;30:313–15.PubMed

32.

Akpek EK, Haddad RS, Winkelstein JA, Gottsch JD. Bilateral consecutive central corneal perforations associated with hypogammaglobulinemia. Ophthalmology. 2000;107:123–6.PubMed

33.

Starr JC, Brasher GW, Dominguez J, Rao A. Retinitis Pigmentosa and Hypogammaglobulinemia. South Med J. 2006;99:989–91.PubMed

34.

Sempere AP, Tahoces M, Palao-Duarte S, Garcia-Perez A. Bilateral optic neuritis in a 26-year-old man with common variable immunodeficiency: a case report. J Med Case Rep. 2011;19:319.

35.

Kashani S, Gazzard G, Jolles S, Larkin G. Asymptomatic choroidal granulomas in common variable immunodeficiency. Clin Experiment Ophthalmol. 2005;33:663–4.PubMed

36.

McCannel CA, Pulido JS. Diffuse placoid choroidopathy in a patient with common variable immunodeficiency. Int Arch Allergy Immunol. 2008;147:84–6.PubMed

37.

Ooi KG, Joshua F, Broadfoot A. Recurrent multi-organism keratoconjunctivitis manifesting as a first presentation of common variable immune deficiency (CVID). Ocul Immunol Inflamm. 2007;15:403–5.PubMed

38.

Aghamohammadi A, Abolhassani H, Hirbod-Mobarakeh A, Ghassemi F, Shahinpour S, Behniafard N, et al. The uncommon combination of common variable immunodeficiency, macrophage activation syndrome, and cytomegalovirus retinitis. Viral Immunol. 2012;25:161–5.PubMed

39.

Hammarstrom L, Smith C. Genetic approach to common variable immunodeficiency and IgA deficiency. In: Ochs H, Smith C, Puck J, editors. Primary immunodeficiency diseases: a molecular and genetic approach. New York: Oxford University Press; 2007. p. 313–25.

40.

Aghamohammadi A, Cheraghi T, Gharagozlou M, Movahedi M, Rezaei N, Yeganeh M, et al. IgA deficiency: correlation between clinical and immunological phenotypes. J Clin Immunol. 2009;29:130–6.PubMed

41.

Cunningham–Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol. 2001;21:303–9.PubMed

42.

Addison DJRA. Immunoglobulin A (IgA) deficiency and eye disease. Trans Ophthalmol Soc Uk. 1981;101:9–11.PubMed

43.

Goldstein MF, Goldstein AL, Dunsky EH, Dvorin DJ, Belecanech GA, Shamir K. Selective IgM immunodeficiency: retrospective analysis of 36 adult patients with review of the literature. Ann Allergy Asthma Immunol. 2006;97:717–30.PubMed

44.

Yel L, Ramanuja S, Gupta S. Clinical and immunological features in IgM deficiency. Int Arch Allergy Immunol. 2009;150:291–8.PubMed

45.

Guill MF, Brown DA. IgM deficiency: clinical spectrum and immunologic assessment. Ann Allergy. 1989;62:547–52.PubMed

46.

Kiratli HK, Akar Y. Multiple recurrent hordeola associated with selective IgM deficiency. J AAPOS. 2001;5:60–1.PubMed

47.

Movahedi M, Aghamohammadi A, Rezaei N, Shahnavaz N, Jandaghi AB, Farhoudi A, et al. Chronic granulomatous disease: a clinical survey of 41 patients from the Iranian primary immunodeficiency registry. Int Arch Allergy Immunol. 2004;134:253–9.PubMed

48.

Seger RA. Modern management of chronic granulomatous disease. Br J Haematol. 2008;140:255–66.PubMed

49.

Winkelstein JA, Marino MC, Johnston RBJ, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79:155–69.

50.

Martyn L, Lischner HW, Pileggi AJ, Harley RD. Chorioretinal lesions in familial chronic granulomatous disease of childhood. Am J Ophthalmol. 1972;73:403–18.PubMed

51.

Palestine AG, Meyers SM, Fauci AS, Gallin JI. Ocular findings in patients with neutrophil dysfunction. Am J Ophthalmol. 1983;95:598–604.PubMed

52.

Goldblatt D, Butcher J, Thrasher AJ, Russell-Eggitt I. Chorioretinal lesions in patients and carriers of chronic granulomatous disease. J Pediatr. 1999;134:780–3.PubMed

53.

Grossniklaus HE, Frank KE, Jacobs G. Chorioretinal lesions in chronic granulomatous disease of childhood. Clinicopathologic correlations. Retina. 1988;8:270–4.PubMed

54.

Barequet IS, Wygnanski-Jaffe T, Spierer A, Moisseiev J. Ophthalmic diagnosis of chronic granulomatous disease. J Pediatr Ophthalmol Strabismus. 2002;39:44–5.PubMed

55.

Kim SJ, Kim JG, Yu YS. Chorioretinal lesions in patients with chronic granulomatous disease. Retina. 2003;23:360.PubMed

56.

Al-Muhsen S, Al-Hemidan A, Al-Shehri A, Al-Harbi A, Al-Ghonaium A, Al-Saud B, et al. Ocular manifestations in chronic granulomatous disease in Saudi Arabia. J AAPOS. 2009;13:396–9.PubMed

57.

Valluri S, Chu FC, Smith ME. Ocular pathologic findings of chronic granulomatous disease of childhood. Am J Ophthalmol. 1995;120:120–3.PubMed

58.

Wang Y, Marciano BE, Shen D, Bishop RJ, Park S, Holland SM, et al. Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease. J Clin Immunol. 2013;33:917–24.PubMed

59.

Panagiotopoulos M, Sönne H. Chronic granulomatous disease and serious unilateral keratitis with bilateral conjunctivitis: a rare case of external ocular disease. Acta Ophthalmol. 2011;89:296–7.

60.

Matsuura T, Sonoda KH, Ohga S, Ariyama A, Nakamura T, Ishibashi T. A case of chronic recurrent uveitis associated with chronic granulomatous disease. Jpn J Ophthalmol. 2006;50:287–9.PubMed

61.

Djalilian AR, Smith JA, Walsh TJ, Malech HL, Robinson MR. Keratitis Caused by Candida glabrata in a Patient With Chronic Granulomatous Disease. Am J Ophthalmol. 2001;132:782–3.PubMed

62.

Leroux K, Mallon E, Ayliffe WH. Chronic granulomatous disease and peripheral ulcerative keratitis: a rare case of recurrent external ocular disease. Bull Soc Belge Ophtalmol. 2004;293:47–53.PubMed

63.

Mansour AM, Al Dairy M, Hamam R, Hidayat AA. Chronic granulomatous disease presenting as retinal mass. Cases J. 2008;1:257.PubMedCentralPubMed

64.

Keskin-Yildirim Z, Simşek-Derelioğlu S, Kantarci M, Yilmaz Y, Büyükavci M. Papillon-Lefèvre syndrome: report of three cases in the same family. Turk J Pediatr. 2012;54:171–6.PubMed

65.

Ullbro C, Crossner CG, Nederfors T, Alfadley A, Thestrup-Pedersen K. Dermatologic and oral findings in a cohort of 47 patients with Papillon-Lefèvre syndrome. J Am Acad Dermatol. 2003;48:345–51.PubMed

66.

Murthy R, Honavar SG, Vemuganti GK, Burman S, Naik M, Parathasaradhi A. Ocular surface squamous neoplasia in Papillon-Lefevre syndrome. Am J Ophthalmol. 2005;139:207–9.PubMed

67.

Mhaiskar U, Kulkarni S, Shah MD. Papillon-Lefevre syndrome with ocular nystagmus (a case report). J Postgrad Med. 1980;26:267–8.PubMed

68.

Saatci P, Arli AO, Demir K, Saatci AO, Kavakçu S. Corneal involvement in Papillon-Lefèvre syndrome. J Pediatr Ophthalmol Strabismus. 2006;43:167–9.PubMed

69.

el Habbal MH, Strobel S. Leucocyte adhesion deficiency. Arch Dis Child. 1993;69:463–6.PubMed

70.

Kuijpers TW, Van Lier RA, Hamann D, de Boer M, Thung LY, Weening RS, et al. Leukocyte adhesion deficiency type 1 (LAD-1)/variant. A novel immunodeficiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest. 1997;100:1725–33.PubMedCentralPubMed

71.

Parvaneh N, Mamishi S, Rezaei A, Rezaei N, Tamizifar B, Parvaneh L, et al. Characterization of 11 new cases of leukocyte adhesion deficiency type 1 with seven novel mutations in the ITGB2 gene. J Clin Immunol. 2010;30:756–60.PubMed

72.

Kavehmanesh Z, Matinzadeh ZK, Amirsalari S, Torkaman M, Afsharpayman S, Javadipour M. Leukocyte adhesion deficiency: report of two family related newborn infants. Acta Med Iran. 2010;48:273–6.PubMed

73.

Ganesh A, Al-Zuhaibi SS, Bialasiewicz AA, Al-Abri R, Ahmed S, Al-Tamemi S, et al. Necrotizing Pseudomonas infection of the ocular adnexa in an infant with leukocyte adhesion defect. J Pediatr Ophthalmol Strabismus. 2007;44:199–200.PubMed

74.

Sá NB, Guerini MB, Barbato MT, Di Giunta G, Nunes DH. Epidermodysplasia verruciformis: clinical presentation with varied forms of lesions. An Bras Dermatol. 2011;86:S57–60.PubMed

75.

Tornesello ML, Duraturo ML, Waddell KM, Biryahwaho B, Downing R, Balinandi S, et al. Evaluating the role of human papillomaviruses in conjunctival neoplasia. Br J Cancer. 2006;94:446–9.PubMedCentralPubMed

76.

Sharquie KE, Al-Meshhadani SA, Al-Nuaimy AA. Invasive squamous cell carcinoma of the eyes in patients with epidermodysplasia verruciformis. Saudi Med J. 2007;28:787–90.PubMed

77.

Ateenyi-Agaba C, Weiderpass E, Smet A, Dong W, Dai M, Kahwa B, et al. Epidermodysplasia verruciformis human papillomavirus types and carcinoma of the conjunctiva: a pilot study. Br J Cancer. 2004;90:1777–9.PubMedCentralPubMed

78.

Engelhardt KR, Grimbacher B. Mendelian traits causing susceptibility to mucocutaneous fungal infections in human subjects. J Allergy Clin Immunol. 2012;129:294–305.PubMed

79.

Uzel G, Sampaio EP, Lawrence MG, Hsu AP, Hackett M, Dorsey MJ, et al. Dominant gain-of-function STAT1 mutations in FOXP3 wild-type immune dysregulation-polyendocrinopathy-enteropathy-X-linked-like syndrome. J Allergy Clin Immunol. 2013;131:1611–23.e3.PubMed

80.

Kirkpatrick CH. Chronic mucocutaneous candidiasis. Pediatr Infect Dis J. 2001;20:197–206.PubMed

81.

Coleman R, Hay RJ. Chronic mucocutaneous candidiasis associated with hypothyroidism; a distinct syndrome. Br J Dermatol. 1997;136:24–9.PubMed

82.

Merenmies L, Tarkkanen A. Chronic bilateral keratitis in autoimmune polyendocrinopathy-candidiadis-ectodermal dystrophy (APECED). A long-term follow-up and visual prognosis. Acta Ophthalmol Scand. 2000;78:532–5.PubMed

83.

Gass JD. The syndrome of keratoconjunctivitis, superficial moniliasis, idiopathic hypoparathyroidism and Addison’s disease. Am J Ophthalmol. 1962;54:660–74.PubMed

84.

Trabulsi EI, Azar DT, Jarudi NJ, Der Kalousian VM. Ocular findings in the candidiasis- endocrinopathy syndrome. Ophthalmol. 1985;99:486–87.

85.

Wagman RD, Kazdan JJ, Kooh SW, Fraser D. Keratitis associated with the multiple endocrine deficiency, autoimmune disease, and candidiasis syndrome. Am J Ophthalmol. 1987;103:569–75.PubMed

86.

Yildiz EH, Saad CG, Eagle R, Ayres BD, Cohen EJ. The Boston keratoprosthesis in 2 patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. Cornea. 2010;29:354–6.PubMed

87.

Tarkkanen A, Merenmies L. Corneal pathology and outcome of keratoplasty in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED). Acta Ophthalmol Scand. 2001;79:204–7.PubMed

88.

Chang B, Brosnahan D, McCreery K, Dominguez M, Costigan C. Ocular complications of autoimmune polyendocrinopathy syndrome type 1. J AAPOS. 2006;10:515–20.PubMed

89.

Carboni I, Soda R, Bianchi L, Chimenti S. Chronic mucocutaneous candidiasis and alopecia areata as cutaneous expressions of autoimmune polyglandular syndrome type I. Acta Derm Venereol. 2002;82:68–9.PubMed

90.

Wengraf DA, McDonagh AJ, Lovewell TR, Vasilopoulos Y, Macdonald-Hull SP, Cork MJ, et al. Genetic analysis of autoimmune regulator haplotypes in alopecia areata. Tissue Antigens. 2008;71:206–12.PubMed

91.

Kaplan J, De Domenico I, Ward DM. Chediak–Higashi syndrome. Curr Opin Hematol. 2008;15:22–9.PubMed

92.

Singh RP, Gupta P, Santendra SB. Chediak–Higashi syndrome—accelerated phase. Indian Pediatr. 1994;31:445–8.PubMed

93.

Rescigno R, Dinowitz M. Ophthalmic Manifestations of Immunodeficiency States. Clin Rev Allergy Immunol. 2001;20:163–81.PubMed

94.

Rezaei N, Moazzami K, Aghamohammadi A, Klein C. Neutropenia and primary immunodeficiency diseases. Int Rev Immunol. 2009;28:335–66.PubMed

95.

Meeths M, Bryceson YT, Rudd E, Zheng C, Wood SM, Ramme K, et al. Clinical presentation of Griscelli syndrome type 2 and spectrum of RAB27A mutations. Pediatr Blood Cancer. 2010;54:563–72.PubMed

96.

Grønskov K, Ek J, Brondum-Nielsen K. Oculocutaneous albinism. Orphanet J Rare Dis. 2007;2:43.PubMedCentralPubMed

97.

Gradstein L, FitzGibbon EJ, Tsilou ET, Rubin BI, Huizing M, Gahl WA. Eye movement abnormalities in hermansky-pudlak syndrome. J AAPOS. 2005;9:369–78.PubMed

98.

Izquierdo NJ, Townsend W, Hussels IE. Ocular findings in the Hermansky-Pudlak syndrome. Trans Am Ophthalmol Soc. 1995;93:191–200.PubMedCentralPubMed

99.

BenEzra D, Mengistu F, Cividalli G, Weizman Z, Merin S, Auerbach E. Chédiak-Higashi syndrome: Ocular findings. J Pediatr Ophthalmol Strabismus. 1980;17:68–74.PubMed

100.

Johnson DL, Jacobson LW, Toyama R, Monahan RH. Histopathology of eyes in Chédiak-Higashi syndrome. Arch Ophthalmol. 1966;75:84–8.PubMed

101.

Valenzuela R, Morningstar WA. The ocular pigmentary disturbance of human Chédiak-Higashi syndrome. A comparative light- and electron-microscopic study and review of the literature. Am J Clin Pathol. 1981;75:591–6.PubMed

102.

Sayanagi K, Fujikado T, Onodera T, Tano Y. Chediak-Higashi Syndrome with Progressive Visual Loss. Jpn J Ophthalmol. 2003;47:304–6.PubMed

103.

Haas D, Hoffmann GF. 2006. Mevalonate kinase deficiencies: from mevalonic aciduria to hyperimmunoglobulinemia D syndrome. Orphanet J Rare Dis 1

104.

Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM, et al. Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics. 1993;91:915–21.PubMed

105.

van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, et al. Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet. 1984;19:1087–90.

106.

Bader-Meunier B, Florkin B, Sibilia J, Acquaviva C, Hachulla E, Grateau G, et al. Mevalonate Kinase Deficiency: A Survey of 50 Patients. Pediatrics. 2011;128:152–9.

107.

Becker ML, Rose CD. Blau syndrome and related genetic disorders causing childhood arthritis. Curr Rheumatol Rep. 2005;7:427–33.PubMed

108.

Punzi L, Furlan A, Podswiadek M, Gava A, Valente M, De Marchi M, et al. Clinical and genetic aspects of Blau syndrome: a 25-year follow-up of one family and a literature review. Autoimmun Rev. 2009;8:228–32.PubMed

109.

Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, et al. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheumatol. 2002;46:3041–5.

110.

Blau EB. Familial granulomatous arthritis, iritis, and rash. J Pediatr. 1985;107:689–93.PubMed

111.

Pastores GM, Michels VV, Stickler GB, Su WP, Nelson AM, Bovenmyer DA. Autosomal dominant granulomatous arthritis, uveitis, skin rash, and synovial cysts. J Pediatr. 1990;117:403–8.PubMed

112.

Manouvrier-Hanu S, Puech B, Piette F, Boute-Benejean O, Desbonnet A, Duquesnoy B, et al. Blau syndrome of granulomatous arthritis, iritis, and skin rash: a new family and review of the literature. Am J Med Genet. 1998;76:217–21.PubMed

113.

Cuesta IA, Moore EC, Rabah R, Bawle EV. Blau syndrome (familial granulomatous arthritis, iritis, and rash) in an african-american family. J Clin Rheumatol. 2000;6:30–4.PubMed

114.

Kurokawa T, Kikuchi T, Ohta K, Imai H, Yoshimura N. Ocular Manifestations in Blau Syndrome Associated with a CARD15/Nod2 Mutation. Ophthalmology. 2003;110:2040–4.PubMed

115.

Raiji VR, Miller MM, Jung LK. Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene. J AAPOS. 2011;15:205–7.PubMed

116.

Kubota T, Koike R. Cryopyrin-associated periodic syndromes: background and therapeutics. Mod Rheumatol. 2010;20:213–21.PubMed

117.

Huttenlocher A, Frieden IJ, Emery H. Neonatal onset multisystem inflammatory disease. J Rheumatol. 1995;22:1171–3.PubMed

118.

Prieur AM. A recently recognised chronic inflammatory disease of early onset characterised by the triad of rash, central nervous system involvement and arthropathy. Clin Exp Rheumatol. 2001;19:103–6.PubMed

119.

Dollfus H, Häfner R, Hofmann HM, Russo RA, Denda L, Gonzales LD, et al. Chronic infantile neurological cutaneous and articular/neonatal onset multisystem inflammatory disease syndrome: ocular manifestations in a recently recognized chronic inflammatory disease of childhood. Arch Ophthalmol. 2000;118:1386–92.PubMed

120.

Russo RA, Katsicas MM. Chronic infantile neurological cutaneous and articular syndrome: two new cases with rare manifestations. Acta Paediatr. 2001;90:1076–9.PubMed

121.

Rigante D, Stabile A, Minnella A, Avallone L, Ziccardi L, Bersani G, et al. Post-inflammatory retinal dystrophy in CINCA syndrome. Rheumatol Int. 2010;30:389–93.PubMed

122.

Miura M, Okabe T, Tsubata S, Takizawa N, Sawaguchi T. Chronic infantile neurological cutaneous articular syndrome in a patient from Japan. Eur J Pediatr. 1997;156:624–6.PubMed

123.

Kuo IC, Fan J, Cunningham ET. Ophthalmic Manifestations of Neonatal Onset Multisystem Inflammatory Disease. Am J Ophthalmol. 2000;130:856–8.PubMed

124.

Carzoli A, Maalouf T, Henckes O, Lemelle I, George JL, Angioi K. CINCA syndrome: a rare cause of papilledema. The case of homozygous twins. J Fr Ophtalmol. 2010;33:36–9.PubMed

125.

Chun HH, Gatti RA. Ataxia-telangiectasia, an evolving phenotype. DNA Repair (Amst). 2004;3:1187–96.

126.

Frappart PO, McKinnon PJ. Ataxia-telangiectasia and related diseases. Neuromolecular Med. 2006;8:495–511.PubMed

127.

Taylor AM, Groom A, Byrd PJ. Ataxia-telangiectasia-like disorder (ATLD)—its clinical presentation and molecular basis. DNA Repair (Amst). 2004;3:1219–25.

128.

Moin M, Aghamohammadi A, Kouh IA, Tavassoli S, Rezaei N, Ghaffari SR, et al. Ataxia-telangiectasia in Iran: clinical and laboratory features of 104 patients. Pediatr Neurol. 2007;37:21–8.PubMed

129.

Riise R, Ygge J, Lindman C, Stray-Pedersen A, Bek T, Rødningen OK, et al. Ocular findings in Norwegian patients with ataxia-telangiectasia: a 5 year prospective cohort study. Acta Ophthalmol Scand. 2007;85:557–62.PubMed

130.

Lewis RF, Lederman HM, Crawford TO. Ocular motor abnormalities in ataxia telangiectasia. Ann Neurol. 1999;46:287–95.PubMed

131.

Baloh RW, Yee RD, Boder E. Eye movements in ataxia-telangiectasia. Neurology. 1978;28:1099–104.PubMed

132.

Farr AK, Shalev B, Crawford TO, Lederman HM, Winkelstein JA, Repka MX. Ocular Manifestations of Ataxia-Telangiectasia. Am J Ophthalmol. 2002;134:891–6.PubMed

133.

Khan AO, Oystreck DT, Koenig M, Salih MA. 2008. Ophthalmic features of ataxia telangiectasia-like disorder

134.

German J. Bloom’s syndrome. Dermatol Clin. 1995;13:7–18.PubMed

135.

Seif AE. Pediatric leukemia predisposition syndromes: clues to understanding leukemogenesis. Cancer Genet. 2011;204:227–44.PubMed

136.

Cefle K, Ozturk S, Gozum N, Duman N, Mantar F, Guler K, et al. Lens opacities in Bloom syndrome: case report and review of the literature. Ophthalmic Genet. 2007;28:175–8.PubMed

137.

Bhisitkul RB, Rizen M. Bloom syndrome: multiple retinopathies in a chromosome breakage disorder. Br J Ophthalmol. 2004;88:354–7.PubMed

138.

Gibbons B, Scott D, Hungerford JL, Cheung KL, Harrison C, Attard-Montalto S, et al. Retinoblastoma in association with the chromosome breakage syndromes Fanconi’s anaemia and Bloom’s syndrome: clinical and cytogenetic findings. Clin Genet. 1995;47:311–7.PubMed

139.

Dollfus H, Porto F, Caussade P, Speeg-Schatz C, Sahel J, Grosshans E, et al. Ocular manifestations in the inherited DNA repair disorders. Surv Ophthalmol. 2003;48:107–22.PubMed

140.

Aslan D, Oztürk G, Kaya Z, Bideci A, Ozdogãan S, Ozdek S, et al. Early-onset drusen in a girl with bloom syndrome: probable clinical importance of an ocular manifestation. J Pediatr Hematol Oncol. 2004;26:256–7.PubMed

141.

Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst). 2004;3:1207–17.

142.

van der Burgt I, Chrzanowska KH, Smeets D, Weemaes C. Nijmegen breakage syndrome. J Med Genet. 1996;33:153–6.PubMed

143.

Grałek M, Chrzanowska KH, Kanigowska K, Kocyła-Karczmarewicz B. Ocular findings in Nijmegen breakage syndrome. Klin Oczna. 2011;113:153–5.PubMed

144.

Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117:725–38.PubMed

145.

Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125:876–85.PubMed

146.

Podos SM, Einaugler RB, Albert DM, Blaese RM. Ophthalmic manifestations of the Wiskott-Aldrich syndrome. Arch Ophthalmol. 1969;82:322–9.PubMed

147.

Garcez TP, Johnston SL, Unsworth DJ. Wiskott-Aldrich syndrome: acute retinal necrosis as a further late complication. J Clin Pathol. 2010;63:281.PubMed

148.

Freeman AF, Holland SM. Clinical manifestations, etiology, and pathogenesis of the hyper-IgE syndromes. Pediatr Res. 2009;65:32R–7.PubMedCentralPubMed

149.

Rezaei N, Aghamohammadi A. Hyper-IgE syndrome. J Postgrad Med. 2010;56:63–4.PubMed

150.

Minegishi Y, Saito M, Tsuchiya S. Dominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome. Nature. 2007;448:1058–62.PubMed

151.

Engelhardt K, McGhee S, Winkler S, et al. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol. 2009;124:1289–302.e4.PubMedCentralPubMed

152.

Arora V, Kim UR, Khazei HM, Kusagur S. Ophthalmic complications including retinal detachment in hyperimmunoglobulinemia E (Job’s) syndrome: Case report and review of literature. Indian J Ophthalmol. 2009;57:385–6.PubMedCentralPubMed

153.

Patteri P, Serru A, Chessa ML, Loi M, Pinna A. Recurrent giant chalazia in hyperimmunoglobulin E (Job’s) syndrome. Int Ophthalmol. 2009;29:415–7.PubMed

154.

Crama N, Toolens AM, van der Meer JW, Cruysberg JR. Giant chalazia in the hyperimmunoglobulinemia E (hyper-IgE) syndrome. Eur J Ophthalmol. 2004;14:258–60.PubMed

155.

Barrett DJ, Ammann AJ, Wara DW, Cowan MJ, Fisher TJ, Stiehm ER. Clinical and immunologic spectrum of the DiGeorge syndrome. J Clin Lab Immunol. 1981;6:1–6.PubMed

156.

McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90:1–18.

157.

Forbes BJ, Binenbaum G, Edmond JC, DeLarato N, McDonald-McGinn DM, Zackai EH. Ocular findings in the chromosome 22q11.2 deletion syndrome. J AAPOS. 2007;11:179–82.PubMed

158.

Prabhakaran VC, Davis G, Wormald PJ, Selva D. Congenital absence of the nasolacrimal duct in velocardiofacial syndrome. J AAPOS. 2008;12:85–6.PubMed

159.

Casteels I, Devriendt K. Unilateral Peters’ anomaly in a patient with DiGeorge syndrome. J Pediatr Ophthalmol Strabismus. 2005;42:311–3.PubMed

160.

Gottlieb C, Li Z, Uzel G, Nussenblatt RB, Sen HN. Uveitis in DiGeorge syndrome: a case of autoimmune ocular inflammation in a patient with deletion 22q11.2. Ophthalmic Genet. 2010;31:24–9.PubMedCentralPubMed

161.

Binenbaum G, McDonald-McGinn DM, Zackai EH, Walker BM, Coleman K, Mach AM, et al. Sclerocornea associated with the chromosome 22q11.2 deletion syndrome. Am J Med Genet A. 2008;146:904–9.PubMedCentralPubMed

162.

Corsten-Janssen N, Saitta SC, Hoefsloot LH, McDonald-McGinn DM, Driscoll DA, Derks R, et al. More Clinical Overlap between 22q11.2 Deletion Syndrome and CHARGE Syndrome than Often Anticipated. Mol Syndromol. 2013;4:235–45.PubMedCentralPubMed

163.

Zentner GE, Layman WS, Martin DM, Scacheri PC. Molecular and phenotypic aspects of CHD7 mutation in CHARGE syndrome. Am J Med Genet A. 2010;152A:674–86.PubMedCentralPubMed

164.

McMain K, Blake K, Smith I, Johnson J, Wood E, Tremblay F, et al. Ocular features of CHARGE syndrome. J AAPOS. 2008;12:460–5.PubMed

165.

Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, et al. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet. 2002;30:215–20.PubMed

166.

Boerkoel CF, O’Neill S, André JL, Benke PJ, Bogdanovíć R, Bulla M, et al. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr. 2000;159:1–7.PubMed

167.

Saraiva JM, Dinis A, Resende C, Faria E, Gomes C, Correia AJ, et al. Schimke immuno-osseous dysplasia: case report and review of 25 patients. J Med Genet. 1999;36:786–9.PubMed

168.

Dokal I, Vulliamy T. Inherited aplastic anaemias/bone marrow failure syndromes. Blood Rev. 2008;22:141–53.PubMed

169.

Kirwan M, Dokal I. Dyskeratosis congenita: A genetic disorder of many faces. Clin Genet. 2008;73:103–12.PubMed

170.

Mason PJ, Wilson DB, Bessler M. Dyskeratosis congenita – a disease of dysfunctional telomere maintenance. Curr Mol Med. 2005;5:159–70.PubMed

171.

Nazir S, Sayani N, Phillips PH. Retinal hemorrhages in a patient with dyskeratosis congenita. J AAPOS. 2008;12:415–7.PubMed

172.

Johnson CA, Hatfield M, Pulido JS. Retinal vasculopathy in a family with autosomal dominant dyskeratosis congenita. Ophthalmic Genet. 2009;30:181–4.PubMed

173.

Teixeira LF, Shields CL, Marr B, Horgan N, Shields JA. Bilateral retinal vasculopathy in a patient with dyskeratosis congenita. Arch Ophthalmol. 2008;126:134–5.PubMed

174.

Tsilou ET, Giri N, Weinstein S, Mueller C, Savage SA, Alter BP. Ocular and orbital manifestations of the inherited bone marrow failure syndromes: Fanconi anemia and dyskeratosis congenita. Ophthalmology. 2010;117:615–22.PubMedCentralPubMed

175.

Aslan D, Ozdek S, Camurdan O, Bideci A, Cinaz P. Dyskeratosis congenita with corneal limbal insufficiency. Pediatr Blood Cancer. 2009;53:95–7.PubMed

176.

Aslan D, Akata RF. Dyskeratosis congenita and limbal stem cell deficiency. Exp Eye Res. 2010;90:472–3.PubMed

177.

Menon V, Kumar A, Verma L. Zinsser-Cole-Engman syndrome (dyskeratosis congenita) with cataract–a rare association. Jpn J Ophthalmol. 1986;30:192–6.PubMed

178.

Zagorski Z, Biziorek B, Rakowska E, Jedrzejewski D. Zinsser-Engman-Cole syndrome (dyskeratosis congenita) with severe sicca syndrome, panuveitis and corneal perforation. Klin Monatsbl Augenheilkd. 2001;218:455–8.PubMed

179.

Merchant A, Zhao TZ, Foster CS. Chronic keratoconjunctivitis associated with congenital dyskeratosis and erythrokeratodermia variablis: two rare genodermatoses. Ophthalmology. 1998;105:1286–91.PubMed

180.

Reichel M, Grix AC, Isseroff RR. Dyskeratosis congenita associated with elevated fetal hemoglobin, X-linked ocular albinism, and juvenile-onset diabetes mellitus. Pediatr Dermatol. 1992;9:103–6.PubMed

181.

Adam MP, Hudgins L. Kabuki syndrome: a review. Clin Genet. 2005;67:209–19.PubMed

182.

Micale L, Augello B, Fusco C, Selicorni A, Loviglio MN, Silengo MC, et al. Mutation spectrum of MLL2 in a cohort of Kabuki syndrome patients. Orphanet J Rare Dis. 2011;9:38.

183.

Kluijt I, van Dorp DB, Kwee ML, Toutain A, Keppler-Noreuil K, Warburg M, et al. Kabuki syndrome - report of six cases and review of the literature with emphasis on ocular features. Ophthalmic Genet. 2000;21:51–61.PubMed

184.

Kim NG, Kim HJ, Hwang JM. Strabismus and poor stereoacuity associated with Kabuki syndrome. Korean J Ophthalmol. 2011;25:136–8.PubMedCentralPubMed

185.

Ming JE, Russell KL, Bason L, McDonald-McGinn D, Zackai EH. Coloboma and other ophthalmologic anomalies in Kabuki syndrome: distinction from charge association. Am J Med Genet A. 2003;123A:249–52.PubMed

186.

Turner C, Lachlan K, Amerasinghe N, Hodgkins P, Maloney V, Barber J, et al. Kabuki syndrome: new ocular findings but no evidence of 8p22-p23.1 duplications in a clinically defined cohort. Eur J Hum Genet. 2005;13:716–20.PubMed

187.

Chaudhry IA, Shamsi FA, Alkuraya HS, Al-Sharif A. Ocular manifestations in Kabuki syndrome: the first report from Saudi Arabia. Int Ophthalmol. 2008;28:131–4.PubMed

188.

Evans SL, Kumar N, Rashid MH, Hughes DS. New ocular findings in a case of Kabuki syndrome. Eye (Lond). 2004;18:322–4.

189.

Anandan M, Porter NJ, Nemeth AH, Blair E, Downes SM. Coats-type retinal telangiectasia in case of Kabuki make-up syndrome (Niikawa-Kuroki syndrome). Ophthalmic Genet. 2005;26:181–3.PubMed

190.

Chuah JL, Chuah JK, Brown R. New fundus findings in a case of Kabuki syndrome. Eye (Lond). 2009;23:1483–5.

191.

Emmert-Buck LT, Preslan MW, Kathuria SS. Jaw-winking ptosis in a patient with Kabuki syndrome. J Pediatr Ophthalmol Strabismus. 2004;41:369–72.PubMed

192.

Douzgou S, Petersen MB. Clinical variability of genetic isolates of Cohen syndrome. Clin Genet. 2011;79:501–6.PubMed

193.

Kivitie-Kallio S, Rajantie J, Juvonen E, Norio R. Granulocytopenia in Cohen syndrome. Br J Haematol. 1997;98:308–11.PubMed

194.

Falk MJ, Feiler HS, Neilson DE, Maxwell K, Lee JV, Segall SK, et al. Cohen syndrome in the Ohio Amish. Am J Med Genet A. 2004;128A:23–8.PubMed

195.

Summanen P, Kivitie-Kallio S, Norio R, Raitta C, Kivelä T. Mechanisms of myopia in Cohen syndrome mapped to chromosome 8q22. Invest Ophthalmol Vis Sci. 2002;43:1686–93.PubMed

196.

Taban M, Memoracion-Peralta DS, Wang H, Al-Gazali LI, Traboulsi EI. Cohen syndrome: report of nine cases and review of the literature, with emphasis on ophthalmic features. J AAPOS. 2007;11:431–7.PubMed

197.

Mrugacz M, Sredzinska-Kita D, Bakunowicz-Lazarczyk A. Pediatric ophthalmologic findings of Cohen syndrome in twins. J Pediatr Ophthalmol Strabismus. 2005;42:54–6.PubMed

198.

Douzgou S, Samples JR, Georgoudi N, Petersen MB. Ophthalmic findings in the Greek isolate of Cohen syndrome. Am J Med Genet A. 2011;155A:534–9.PubMed

199.

Khan A, Chandler K, Pimenides D, Black GC, Manson FD. Corneal ectasia associated with Cohen syndrome: a role for COH1 in corneal development and maintenance? Br J Ophthalmol. 2006;90:390–1.PubMed

200.

Pettigrew HD, Teuber SS, Gershwin ME. Clinical significance of complement deficiencies. Ann N Y Acad Sci. 2009;1173:108–23.PubMed

201.

Larakebm A, Leroy S, Frémeaux-Bacchi V, Montchilova M, Pelosse B, Dunand O, et al. Ocular involvement in hemolytic uremic syndrome due to factor H deficiency–are there therapeutic consequences? Pediatr Nephrol. 2007;22:1967–70.

202.

Dragon-Durey MA, Frémeaux-Bacchi V, Loirat C, Blouin J, Niaudet P, Deschenes G, et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. J Am Soc Nephrol. 2004;15:787–95.PubMed

203.

McAvoy CE, Silvestri G. Retinal changes associated with type 2 glomerulonephritis. Eye. 2005;19:985–9.PubMed

204.

Montes T, Goicoechea de Jorge E, Ramos R, Gomà M, Pujol O, Sánchez-Corral P, et al. Genetic deficiency of complement factor H in a patient with age-related macular degeneration and membranoproliferative glomerulonephritis. Mol Immunol. 2008;45:2897–904.PubMed

205.

Despriet DD, Klaver CC, Witteman JC, Bergen AA, Kardys I, de Maat MP, et al. Complement factor H polymorphism, complement activators, and risk of age-related macular degeneration. JAMA. 2006;296:301–9.PubMed

206.

Gallego-Pinazo R, Dolz-Marco R, Martinez-Castillo S, Arevalo JF, Diaz-Llopis M. Update on the principles and novel local and systemic therapies for the treatment of non-infectious uveitis. Inflamm Allergy Drug Targets. 2013;12:38–45.PubMed

Title: Ocular Involvement in Primary Immunodeficiency Diseases
Authors: Sima Hosseinverdi
Hassan Hashemi
Asghar Aghamohammadi
Hans D. Ochs
Nima Rezaei
Publication date: 01-01-2014
Publisher: Springer US
Published in: Journal of Clinical Immunology / Issue 1/2014
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-013-9974-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2014

Psychrobacter immobilis Septicemia in a Boy with X-linked Chronic Granulomatous Disease and Fulminant Hepatic Failure

Terminal Deletion of 11q with Significant Late-Onset Combined Immune Deficiency

Intact IFN-γR1 Expression and Function Distinguishes Langerhans Cell Histiocytosis From Mendelian Susceptibility to Mycobacterial Disease

Chronic Granulomatous Disease: Two Decades of Experience From a Tertiary Care Centre in North West India

Renal Amyloidosis in a Patient with X-linked Agammaglobulinemia (Bruton’s Disease) and Bronchiectasis

Allogeneic Bone Marrow Transplantation Appears to Ameliorate IgA Nephropathy in a Patient with X-linked Thrombocytopenia

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage